PackTalk is a blog for the Healthcare Packaging Industry

The FDA Authorizes First COVID-19 Saliva-Based Test for Home


Published on May 20, 2020

With COVID-19 test kits in high demand, the FDA has been authorizing new at-home sample collections to help make tests more accessible.

Until this point, all at-home tests have required collection from a patient’s nose using a nasal swab and saline. But, earlier in May, the FDA approved the first COVID-19 saliva-based at home collection test by Rutgers Clinical Genomics Laboratory. This prescription-only test allows patients to collect their own sample, easily and safely, without requiring a trip to the doctor’s office.

Saliva-based testing has been found to be just as accurate, if not more so, than nasal testing and the sample is easier, safer and more comfortable to attain.

Learn more about this at home test kit here.


Comments (0)

Related Articles

How to Assess a Failure Observed Post-Transit

October 31, 2020

Transit failures happen. In fact, one in three transit or distribution studies that come through our lab fail. Sometimes intentionally to test the limits of a package, other times it can be unexpected and bring a project to a halt. When we know what caused...

Learn More

Package Design for Seniors

October 31, 2020

Designing medical packaging for seniors can be challenging. It requires looking at the packaging through both the needs of the senior, and a child too. Some of the considerations we might make when designing for seniors are counterintuitive to what we might...

Learn More

The Role of Robotics in Packaging Automation

October 31, 2020

The medical packaging industry goes all-in on the role of robotics in retooling how we design, produce, and distribute products.

Ten years (and more) ago, machine vision was an intriguing novelty and the fun factor of our trade shows. Today, AI and robotics...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.